158 related articles for article (PubMed ID: 34352351)
1. 3,5,6-trichloro-2-pyridinol intensifies the effect of chlorpyrifos on the paracrine function of Sertoli cells by preventing binding of testosterone and the androgen receptor.
Gao H; Li J; Zhao G; Li Y
Toxicology; 2021 Aug; 460():152883. PubMed ID: 34352351
[TBL] [Abstract][Full Text] [Related]
2. TCP structure intensified the chlorpyrifos-induced decrease in testosterone synthesis via LH-LHR-PKA-CREB-Star pathway.
Li J; Fang B; Ren F; Xing H; Zhao G; Yin X; Pang G; Li Y
Sci Total Environ; 2020 Jul; 726():138496. PubMed ID: 32481206
[TBL] [Abstract][Full Text] [Related]
3. Effects of chlorpyrifos and trichloropyridinol on HEK 293 human embryonic kidney cells.
Van Emon JM; Pan P; van Breukelen F
Chemosphere; 2018 Jan; 191():537-547. PubMed ID: 29059561
[TBL] [Abstract][Full Text] [Related]
4. Disruption of androgen receptor signaling by chlorpyrifos (CPF) and its environmental degradation products: a structural insight.
Hazarika J; Ganguly M; Borgohain G; Sarma S; Bhuyan P; Mahanta R
J Biomol Struct Dyn; 2022 Aug; 40(13):6027-6038. PubMed ID: 33480323
[TBL] [Abstract][Full Text] [Related]
5. Hepatotoxicity and nephrotoxicity induced by the chlorpyrifos and chlorpyrifos-methyl metabolite, 3,5,6-trichloro-2-pyridinol, in orally exposed mice.
Deng Y; Zhang Y; Lu Y; Zhao Y; Ren H
Sci Total Environ; 2016 Feb; 544():507-14. PubMed ID: 26674679
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos.
Timchalk C; Poet TS; Kousba AA
Toxicology; 2006 Mar; 220(1):13-25. PubMed ID: 16343727
[TBL] [Abstract][Full Text] [Related]
7. Determination of biological reference values for chlorpyrifos metabolites in human urine using a toxicokinetic approach.
Bouchard M; Carrier G; Brunet RC; Bonvalot Y; Gosselin NH
J Occup Environ Hyg; 2005 Mar; 2(3):155-68. PubMed ID: 15764539
[TBL] [Abstract][Full Text] [Related]
8. Molecular interactions of chlorpyrifos and its environmental degradation products with human sex hormone-binding globulin: an in silico study.
Hazarika J; Ganguly M; Mahanta R
J Appl Toxicol; 2019 Jul; 39(7):1002-1011. PubMed ID: 30815923
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of the organophosphorus insecticide chlorpyrifos and its major metabolites diethylphosphate, diethylthiophosphate and 3,5,6-trichloro-2-pyridinol in the rat.
Timchalk C; Busby A; Campbell JA; Needham LL; Barr DB
Toxicology; 2007 Jul; 237(1-3):145-157. PubMed ID: 17590257
[TBL] [Abstract][Full Text] [Related]
10. Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat.
Smith JN; Campbell JA; Busby-Hjerpe AL; Lee S; Poet TS; Barr DB; Timchalk C
Toxicology; 2009 Jun; 261(1-2):47-58. PubMed ID: 19397948
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic interaction for a binary mixture of chlorpyrifos and diazinon in the rat.
Timchalk C; Poet TS; Hinman MN; Busby AL; Kousba AA
Toxicol Appl Pharmacol; 2005 May; 205(1):31-42. PubMed ID: 15885262
[TBL] [Abstract][Full Text] [Related]
12. Noncholinesterase mechanisms of chlorpyrifos neurotoxicity: altered phosphorylation of Ca2+/cAMP response element binding protein in cultured neurons.
Schuh RA; Lein PJ; Beckles RA; Jett DA
Toxicol Appl Pharmacol; 2002 Jul; 182(2):176-85. PubMed ID: 12140181
[TBL] [Abstract][Full Text] [Related]
13. A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans.
Timchalk C; Nolan RJ; Mendrala AL; Dittenber DA; Brzak KA; Mattsson JL
Toxicol Sci; 2002 Mar; 66(1):34-53. PubMed ID: 11861971
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of chlorpyrifos and 3,5,6-trichloro-2-pyridinol in rat saliva after chlorpyrifos administration.
Smith JN; Wang J; Lin Y; Klohe EM; Timchalk C
Toxicol Sci; 2012 Dec; 130(2):245-56. PubMed ID: 22874420
[TBL] [Abstract][Full Text] [Related]
15. Health risk assessment of exposure to chlorpyrifos in pregnant women using deterministic and probabilistic approaches.
Taheri E; Amin MM; Daniali SS; Abdollahpour I; Fatehizadeh A; Kelishadi R
PLoS One; 2022; 17(1):e0262127. PubMed ID: 35051200
[TBL] [Abstract][Full Text] [Related]
16. Novel degradation pathways for Chlorpyrifos and 3, 5, 6-Trichloro-2-pyridinol degradation by bacterial strain Bacillus thuringiensis MB497 isolated from agricultural fields of Mianwali, Pakistan.
Ambreen S; Yasmin A
Pestic Biochem Physiol; 2021 Feb; 172():104750. PubMed ID: 33518043
[TBL] [Abstract][Full Text] [Related]
17. A computational insight into the molecular interactions of chlorpyrifos and its degradation products with the human progesterone receptor leading to endocrine disruption.
Hazarika J; Ganguly M; Mahanta R
J Appl Toxicol; 2020 Mar; 40(3):434-443. PubMed ID: 31889325
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to excess chromium attenuates transcription factors regulating expression of androgen and follicle stimulating hormone receptors in Sertoli cells of prepuberal rats.
Shobana N; Kumar MK; Navin AK; Akbarsha MA; Aruldhas MM
Chem Biol Interact; 2020 Sep; 328():109188. PubMed ID: 32679048
[TBL] [Abstract][Full Text] [Related]
19. Expression of Th1/Th2 cytokines in human blood after in vitro treatment with chlorpyrifos, and its metabolites, in combination with endotoxin LPS and allergen Der p1.
Duramad P; Tager IB; Leikauf J; Eskenazi B; Holland NT
J Appl Toxicol; 2006; 26(5):458-65. PubMed ID: 16871525
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics of chlorpyrifos versus its major metabolites following oral administration in the rat.
Busby-Hjerpe AL; Campbell JA; Smith JN; Lee S; Poet TS; Barr DB; Timchalk C
Toxicology; 2010 Jan; 268(1-2):55-63. PubMed ID: 19963030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
